Company Filing History:
Years Active: 2010
Title: Richard Jones - Innovator in Angiogenesis Inhibition
Introduction
Richard Jones is a notable inventor based in Sheffield, GB. He has made significant contributions to the field of medical science, particularly in the area of angiogenesis inhibition. His work focuses on the development of innovative treatments for various diseases.
Latest Patents
Richard Jones holds a patent for "Transglutaminase for inhibiting angiogenesis." This invention relates to the use of transglutaminase in the preparation of a medicament aimed at inhibiting angiogenesis. The patent emphasizes the use of human tissue transglutaminase, which is advantageous for treating conditions such as cancer, rheumatoid arthritis, retinopathy, and psoriasis. The invention also includes compositions that contain transglutaminase in sufficient amounts to effectively inhibit angiogenesis.
Career Highlights
Richard Jones is affiliated with Aston University, where he continues to engage in research and development. His work has garnered attention for its potential impact on treating serious medical conditions. With a focus on innovative solutions, he has established himself as a key figure in his field.
Collaborations
Richard collaborates with Martin Griffin, a fellow researcher, to further explore the applications of his inventions. Their partnership enhances the research efforts at Aston University and contributes to the advancement of medical treatments.
Conclusion
Richard Jones is a pioneering inventor whose work in angiogenesis inhibition holds promise for treating various diseases. His contributions to medical science are significant and continue to inspire further research and innovation.